Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1995 Jul 3;92(14):6617–6619. doi: 10.1073/pnas.92.14.6617

Ergosteroids: induction of thermogenic enzymes in liver of rats treated with steroids derived from dehydroepiandrosterone.

H Lardy 1, B Partridge 1, N Kneer 1, Y Wei 1
PMCID: PMC41569  PMID: 7604042

Abstract

Dehydroepiandrosterone (DHEA), an intermediate in the biosynthesis of testosterone and estrogens, exerts several physiological effects not involving the sex hormones. When fed to rats it induces the thermogenic enzymes mitochondrial sn-glycerol-3-phosphate dehydrogenase and cytosolic malic enzyme in their livers. Animals and humans, and their excised tissues, are known to hydroxylate DHEA at several positions and to interconvert 7 alpha-hydroxy-DHEA, 7 beta-hydroxy-DHEA, 7-oxo-DHEA, and the corresponding derivatives of androst-5-enediol. We report here that these 7-oxygenated derivatives are active inducers of these thermogenic enzymes in rats and that the 7-oxo derivatives are more active than the parent steroids. We postulate that the 7 alpha-hydroxy and 7-oxo derivatives are on a metabolic pathway from DHEA to more active steroid hormones. These 7-oxo steroids have potential as therapeutic agents because of their increased activity and because they are not convertible to either testosterone or estrogens.

Full text

PDF
6617

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akwa Y., Morfin R. F., Robel P., Baulieu E. E. Neurosteroid metabolism. 7 alpha-Hydroxylation of dehydroepiandrosterone and pregnenolone by rat brain microsomes. Biochem J. 1992 Dec 15;288(Pt 3):959–964. doi: 10.1042/bj2880959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Amuro Y., Yamade W., Yamamoto T., Maebo A., Hada T., Higashino K. Partial purification and characterization of 7 alpha-hydroxysteroid dehydrogenase from rat liver microsomes. Biochim Biophys Acta. 1987 Jan 13;917(1):101–107. doi: 10.1016/0005-2760(87)90289-x. [DOI] [PubMed] [Google Scholar]
  3. Ben-Nathan D., Lustig S., Kobiler D., Danenberg H. D., Lupu E., Feuerstein G. Dehydroepiandrosterone protects mice inoculated with West Nile virus and exposed to cold stress. J Med Virol. 1992 Nov;38(3):159–166. doi: 10.1002/jmv.1890380302. [DOI] [PubMed] [Google Scholar]
  4. Berdanier C. D., Parente J. A., Jr, McIntosh M. K. Is dehydroepiandrosterone an antiobesity agent? FASEB J. 1993 Mar;7(5):414–419. doi: 10.1096/fasebj.7.5.8462783. [DOI] [PubMed] [Google Scholar]
  5. Bobyleva V., Kneer N., Bellei M., Battelli D., Lardy H. A. Concerning the mechanism of increased thermogenesis in rats treated with dehydroepiandrosterone. J Bioenerg Biomembr. 1993 Jun;25(3):313–321. doi: 10.1007/BF00762592. [DOI] [PubMed] [Google Scholar]
  6. CEDARD L., FILLMANN B., KNUPPEN R., LISBOA B. P., BREUER H. STOFFWECHSEL UND AROMATISIERUNG VON 7-SUBSTITUIERTEN C19-STEROIDEN IN DER PLACENTA. Hoppe Seylers Z Physiol Chem. 1964;338:89–99. doi: 10.1515/bchm2.1964.338.1-2.89. [DOI] [PubMed] [Google Scholar]
  7. Cleary M. P. The antiobesity effect of dehydroepiandrosterone in rats. Proc Soc Exp Biol Med. 1991 Jan;196(1):8–16. doi: 10.3181/00379727-196-43158b. [DOI] [PubMed] [Google Scholar]
  8. Coleman D. L., Schwizer R. W., Leiter E. H. Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes-obesity mutants and in aged normal mice. Diabetes. 1984 Jan;33(1):26–32. doi: 10.2337/diab.33.1.26. [DOI] [PubMed] [Google Scholar]
  9. Couch R. A., Skinner S. J., Tobler C. J., Doouss T. W. The in vitro synthesis of 7-hydroxy dehydroepiandrosterone by human mammary tissues. Steroids. 1975 Jul;26(1):1–15. doi: 10.1016/0039-128x(75)90002-1. [DOI] [PubMed] [Google Scholar]
  10. Einarsson K., Gustafsson J. A., Ihre T., Ingelman-Sundberg M. Specific metabolic pathways of steroid sulfates in human liver microsomes. J Clin Endocrinol Metab. 1976 Jul;43(1):56–63. doi: 10.1210/jcem-43-1-56. [DOI] [PubMed] [Google Scholar]
  11. FUKUSHIMA D. K., KEMP A. D., SCHNEIDER R., STOKEM M. B., GALLAGHER T. F. Studies in steroid metabolism. XXV. Isolation and characterization of new urinary steroids. J Biol Chem. 1954 Sep;210(1):129–137. [PubMed] [Google Scholar]
  12. Faredin I., Fazekas A. G., Tóth I., Kókai K., Julesz M. Transformation in vitro of [4-14-C]-dehydroepiandrosterone into 7-oxygenated derivatives by normal human male and female skin tissue. J Invest Dermatol. 1969 Apr;52(4):357–361. doi: 10.1038/jid.1969.61. [DOI] [PubMed] [Google Scholar]
  13. Flood J. F., Morley J. E., Roberts E. Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1567–1571. doi: 10.1073/pnas.89.5.1567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Johansson G. Oxidation of cholesterol, 3 -hydroxy-5-pregnen-20-one and 3 -hydroxy-5-androsten-17-one by rat liver microsomes. Eur J Biochem. 1971 Jul 15;21(1):68–79. doi: 10.1111/j.1432-1033.1971.tb01441.x. [DOI] [PubMed] [Google Scholar]
  15. Kritchevsky D., Tepper S. A., Klurfeld D. M., Schwartz A. G. Influence of dehydroepiandrosterone (DHEA) on cholesterol metabolism in rats. Pharmacol Res Commun. 1983 Oct;15(9):797–803. doi: 10.1016/s0031-6989(83)80087-3. [DOI] [PubMed] [Google Scholar]
  16. Kurzman I. D., MacEwen E. G., Haffa A. L. Reduction in body weight and cholesterol in spontaneously obese dogs by dehydroepiandrosterone. Int J Obes. 1990 Feb;14(2):95–104. [PubMed] [Google Scholar]
  17. LEE Y. P., LARDY H. A. INFLUENCE OF THYROID HORMONES ON L-ALPHA-GLYCEROPHOSPHATE DEHYDROGENASES AND OTHER DEHYDROGENASES IN VARIOUS ORGANS OF THE RAT. J Biol Chem. 1965 Mar;240:1427–1436. [PubMed] [Google Scholar]
  18. LEE Y. P., TAKEMORI A. E., LARDY H. Enhanced oxidation of alpha-glycerophosphate by mitochondria of thyroid-fed rats. J Biol Chem. 1959 Nov;234:3051–3054. [PubMed] [Google Scholar]
  19. Loria R. M., Inge T. H., Cook S. S., Szakal A. K., Regelson W. Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA). J Med Virol. 1988 Nov;26(3):301–314. doi: 10.1002/jmv.1890260310. [DOI] [PubMed] [Google Scholar]
  20. Morales A. J., Nolan J. J., Nelson J. C., Yen S. S. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab. 1994 Jun;78(6):1360–1367. doi: 10.1210/jcem.78.6.7515387. [DOI] [PubMed] [Google Scholar]
  21. Morfin R., Courchay G. Pregnenolone and dehydroepiandrosterone as precursors of native 7-hydroxylated metabolites which increase the immune response in mice. J Steroid Biochem Mol Biol. 1994 Jul;50(1-2):91–100. doi: 10.1016/0960-0760(94)90176-7. [DOI] [PubMed] [Google Scholar]
  22. Mortola J. F., Yen S. S. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab. 1990 Sep;71(3):696–704. doi: 10.1210/jcem-71-3-696. [DOI] [PubMed] [Google Scholar]
  23. Nestler J. E., Barlascini C. O., Clore J. N., Blackard W. G. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab. 1988 Jan;66(1):57–61. doi: 10.1210/jcem-66-1-57. [DOI] [PubMed] [Google Scholar]
  24. Padgett D. A., Loria R. M. In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol, and androstenetriol. J Immunol. 1994 Aug 15;153(4):1544–1552. [PubMed] [Google Scholar]
  25. Rao M. S., Subbarao V., Yeldandi A. V., Reddy J. K. Inhibition of spontaneous testicular Leydig cell tumor development in F-344 rats by dehydroepiandrosterone. Cancer Lett. 1992 Aug 14;65(2):123–126. doi: 10.1016/0304-3835(92)90155-o. [DOI] [PubMed] [Google Scholar]
  26. STARKA L., KUTOVA J. 7-Hydroxylation of dehydroepiandrosterone by rat-liver homogenate. Biochim Biophys Acta. 1962 Jan 1;56:76–82. doi: 10.1016/0006-3002(62)90528-0. [DOI] [PubMed] [Google Scholar]
  27. Schwartz A. G. Inhibition of spontaneous breast cancer formation in female C3H(Avy/a) mice by long-term treatment with dehydroepiandrosterone. Cancer Res. 1979 Mar;39(3):1129–1132. [PubMed] [Google Scholar]
  28. Sonderfan A. J., Arlotto M. P., Parkinson A. Identification of the cytochrome P-450 isozymes responsible for testosterone oxidation in rat lung, kidney, and testis: evidence that cytochrome P-450a (P450IIA1) is the physiologically important testosterone 7 alpha-hydroxylase in rat testis. Endocrinology. 1989 Aug;125(2):857–866. doi: 10.1210/endo-125-2-857. [DOI] [PubMed] [Google Scholar]
  29. Su C. Y., Lardy H. Induction of hepatic mitochondrial glycerophosphate dehydrogenase in rats by dehydroepiandrosterone. J Biochem. 1991 Aug;110(2):207–213. doi: 10.1093/oxfordjournals.jbchem.a123558. [DOI] [PubMed] [Google Scholar]
  30. Sulcová J., Stárka L. Characterisation of microsomal dehydroepiandrosterone 7-hydroxylase from rat liver. Steroids. 1968 Jul;12(1):113–126. doi: 10.1016/s0039-128x(68)80084-4. [DOI] [PubMed] [Google Scholar]
  31. Sunde A., Aareskjold K., Haug E., Eik-Nes K. B. Synthesis and androgen effects of 7 alpha,17 beta-dihydroxy-5 alpha-androstan-3-one, 5 alpha-androstan-3 alpha,7 alpha,17 beta-triol and 5 alpha-androstane-3 beta,7 alpha,17 beta-triol. J Steroid Biochem. 1982 Mar;16(3):483–488. doi: 10.1016/0022-4731(82)90064-4. [DOI] [PubMed] [Google Scholar]
  32. TEPPERMAN H. M., TEPPERMAN J. PATTERNS OF DIETARY AND HORMONAL INDUCTION OF CERTAIN NADP-LINKED LIVER ENZYMES. Am J Physiol. 1964 Feb;206:357–361. doi: 10.1152/ajplegacy.1964.206.2.357. [DOI] [PubMed] [Google Scholar]
  33. Tagliaferro A. R., Davis J. R., Truchon S., Van Hamont N. Effects of dehydroepiandrosterone acetate on metabolism, body weight and composition of male and female rats. J Nutr. 1986 Oct;116(10):1977–1983. doi: 10.1093/jn/116.10.1977. [DOI] [PubMed] [Google Scholar]
  34. Tepperman H. M., De la Garza S. A., Tepperman J. Effects of dehydroepiandrosterone and diet protein on liver enzymes and lipogenesis. Am J Physiol. 1968 May;214(5):1126–1132. doi: 10.1152/ajplegacy.1968.214.5.1126. [DOI] [PubMed] [Google Scholar]
  35. Usiskin K. S., Butterworth S., Clore J. N., Arad Y., Ginsberg H. N., Blackard W. G., Nestler J. E. Lack of effect of dehydroepiandrosterone in obese men. Int J Obes. 1990 May;14(5):457–463. [PubMed] [Google Scholar]
  36. Welle S., Jozefowicz R., Statt M. Failure of dehydroepiandrosterone to influence energy and protein metabolism in humans. J Clin Endocrinol Metab. 1990 Nov;71(5):1259–1264. doi: 10.1210/jcem-71-5-1259. [DOI] [PubMed] [Google Scholar]
  37. Yen T. T., Allan J. A., Pearson D. V., Acton J. M., Greenberg M. M. Prevention of obesity in Avy/a mice by dehydroepiandrosterone. Lipids. 1977 May;12(5):409–413. doi: 10.1007/BF02533624. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES